Prevalence and Diagnosis of Diabetic Cardiovascular Autonomic Neuropathy in Beijing, China: A Retrospective Multicenter Clinical Study

被引:14
|
作者
Pan, Qi [1 ]
Li, Quanmin [2 ]
Deng, Wei [3 ]
Zhao, Dong [4 ]
Qi, Lin [5 ]
Huang, Wei [6 ]
Ma, Li [7 ]
Li, Hongmei [8 ]
Li, Yufeng [9 ]
Lyu, Xiaofeng [10 ]
Wang, Aihong [11 ]
Yao, Hebin [12 ]
Guo, Lixin [1 ]
Xing, Xiaoyan [13 ]
机构
[1] Beijing Hosp, Natl Ctr Gerontol, Dept Endocrinol, Beijing, Peoples R China
[2] PLA Rocket Force Characterist Med Ctr, Beijing, Peoples R China
[3] Beijing Jishuitan Hosp, Dept Endocrinol, Beijing, Peoples R China
[4] Capital Med Univ, Luhe Hosp, Ctr Endocrine Metab & Immune Dis, Beijing, Peoples R China
[5] Beijing Yanhua Hosp, Dept Endocrinol, Beijing, Peoples R China
[6] Beijing Haidian Hosp, Dept Endocrinol, Beijing, Peoples R China
[7] China Acad Chinese Med Sci, Guanganmen Hosp, Dept Endocrinol, South Sect, Beijing, Peoples R China
[8] Emergency Gen Hosp, Dept Endocrinol, Beijing, Peoples R China
[9] Beijing Pinggu Hosp, Dept Endocrinol, Beijing, Peoples R China
[10] Peoples Liberat Army Gen Hosp, Med Ctr 7, Dept Endocrinol, Beijing, Peoples R China
[11] PIA Strateg Support Force Characterist Med Ctr, Beijing, Peoples R China
[12] Peoples Liberat Army Gen Hosp, Med Ctr 6, Dept Endocrinol, Beijing, Peoples R China
[13] China Japan Friendship Hosp, Dept Endocrinol, Beijing, Peoples R China
关键词
cardiovascular autonomic neuropathy; diabetes mellitus; risk factors; diagnostic method; a Multicenter Clinical Study; HEART-RATE-VARIABILITY; RENAL-FUNCTION; RISK-FACTOR; MELLITUS; TESTS; DETERIORATION; PROGRESSION; ANEMIA;
D O I
10.3389/fnins.2019.01144
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Cardiovascular autonomic neuropathy (CAN) is a debilitating condition occurring among diabetic patients especially those with long duration of disease. Whereas incidences and treatment of CAN has been well described for Western populations, fewer studies have been conducted among the Chinese. This study, therefore, aimed to assess the prevalence of CAN among sampled Chinese diabetic patients. Accordingly, 2,048 participants with a history of type 1 diabetes mellitus (T1DM, 73) and type 2 diabetes mellitus (T2DM, 1975) were randomly sampled from 13 hospitals. Patients' biodata were recorded, and autonomic nervous system function tests performed to aid in the preliminary diagnosis of CAN. The final CAN diagnosis was based on the Ewing's test in which heart rate variation (HRV) values were evaluated through deep-breathing (DB), lying-to-standing (LS), and Valsalva (V) tests. Systolic blood pressure (SBP) variation values were also evaluated through LS. In the T1DM group, 61.6% patients were diagnosed with CAN and no differences were observed in the baseline and clinical data between this group and those without CAN (P > 0.05). In the T2DM group, 62.6% patients were diagnosed with CAN and statistically significant differences were found between the CAN and non- CAN group with regards to age, duration of diabetes, metformin treatment, retinopathy, and hypertension history (P < 0.05). The most common manifestations of CAN included weakness (28.6%), dizziness (23.4%), frequent urination (19.6%), upper body sweating (18.3%), and nocturia (15.9%). Additionally, duration of disease and age were independent risk factors for CAN in T1DM and T2DM, respectively. On diagnosis, a combination of the V test + LS test provided the highest sensitivity of detecting CAN among T1DM group (sensitivity = 97.6%, AUC = 0.887) while for T2DM category, DB test had the highest sensitivity (83.6%), and maximal AUC (0.856) was found with V test + DB test. The overall prevalence of diabetes with CAN in the study was up to 63%.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Diabetic cardiovascular autonomic neuropathy: clinical significance, diagnosis and therapy
    Kempler, Peter
    Korei, Anna
    ORVOSI HETILAP, 2024, 165 (16) : 602 - 612
  • [2] Diabetic cardiovascular autonomic neuropathy: clinical implications
    Karayannis, Georgios
    Giamouzis, Gregory
    Cokkinos, Dennis V.
    Skoularigis, John
    Triposkiadis, Filippos
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2012, 10 (06) : 747 - 765
  • [3] Diagnosis of diabetic cardiac autonomic neuropathy
    Sztanek Ferenc
    Jebelovszki Eva
    Gaszner Balazs
    Zrinyi Miklos
    Pall Denes
    Kempler Peter
    Harangi Mariann
    ORVOSI HETILAP, 2019, 160 (35) : 1366 - 1375
  • [4] Analysis of a Screening System for Diabetic Cardiovascular Autonomic Neuropathy in China
    Xue, Ying
    Lv, Yubao
    Tang, Zihui
    Dong, Jingcheng
    MEDICAL SCIENCE MONITOR, 2017, 23 : 5354 - 5362
  • [5] Predictors of Cardiovascular Autonomic Neuropathy Onset and Progression in a Cohort of Type 1 Diabetic Patients
    Matta, M.
    Pavy-Le Traon, A.
    Perez-Lloret, S.
    Laporte, C.
    Berdugo, I.
    Nasr, N.
    Hanaire, H.
    Senard, J. M.
    JOURNAL OF DIABETES RESEARCH, 2018, 2018
  • [6] Cardiovascular autonomic neuropathy in type 2 diabetic patients
    Santos Breder, Ikaro Soares
    Sposito, Andrei C.
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2019, 65 (01): : 56 - 60
  • [7] Clinical consequences of cardiovascular autonomic neuropathy in diabetic patients
    G. Jermendy
    Acta Diabetologica, 2003, 40 : s370 - s374
  • [8] Study of Cardiovascular Autonomic Neuropathy in Symptomatic and Asymptomatic Type II Diabetic Patients
    Garikapati, Kranthi Kumar
    Tripathi, Yogesh
    Garg, Rinku
    Garg, Bindu
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2021, 15 (03): : 1069 - 1073
  • [9] Clinical consequences of cardiovascular autonomic neuropathy in diabetic patients
    Jermendy, G
    ACTA DIABETOLOGICA, 2003, 40 (Suppl 2) : S370 - S374
  • [10] Cardiovascular autonomic neuropathy in diabetes: Pathophysiology, clinical assessment and implications
    Duque, Alice
    Mediano, Mauro Felippe Felix
    De Lorenzo, Andrea
    Rodrigues Jr, Luiz Fernando
    WORLD JOURNAL OF DIABETES, 2021, 12 (06)